Loading...
Images of Dimitrios Zardavas
(0 from 0 )1
0
0
News
Conference Big Data to Useful Knowledge OncoDNA - May 3rd 2017
www.oncodna.com
Conference Big Data to Useful Knowledge OncoDNA - 03th May 2017
Network Profiles
LinkedIn: Dimitrios Zardavas, MD | LinkedIn
Dimitrios Zardavas, MD. Associate Scientific Director, Breast International Group (BIG) Locatie Bruxelles, Bruxelles-Capitale, Belgium Bedrijfstak
Business Profiles
Researchgate: Dimitrios Zardavas
Brussels, Belgium
Dimitrios Zardavas | EXCEMED
www.excemed.org
Dimitrios Zardavas. Breast International Group (BIG). Brussels, Belgium. Slide kit. Dimitrios Zardavas. Module VI debate: Is there a cookbook of oncology clinical ...
Books & Literature
PLOS ONE: Are life-saving anticancer drugs reaching all patients?...
journals.plos.org
Background The development of trastuzumab is considered to be one of the greatest improvements in breast cancer treatment in recent years. This study aims to...
Handbook of HER2-targeted agents in breast cancer - Ricardo H...
books.google.de
Breast cancer is the most frequently diagnosed cancer and the leading cause of cancer death in women worldwide, accounting for nearly a quarter of the total...
Molecular Testing in Cancer - Google Books
books.google.de
Molecular Testing in Cancer provides a state of the art review of clinically relevant molecular pathology in cancer. The book provides a brief, easy to read...
Translation and Its Regulation in Cancer Biology and Medicine -...
books.google.de
This book, for the first time, comprehensively assembles and analyzes a large body of information on the role of the fundamental mechanism of the protein...
Related Documents
CiteSeerX — Temsirolimus Is Highly Effective as Third-Line Treatment...
citeseerx.ist.psu.edu
BibTeX @MISC{Ag11temsirolimusis, author = {S. Karger Ag and Dimitrios Zardavas and Alexander Meisel and Panagiotis Samaras and Alexander Knuth and Christoph Renner
The past and future of breast cancer treatment—from the papyrus to...
ecancer.org
The past and future of breast cancer treatment—from the papyrus to individualised treatment approaches Felipe Ades1, Konstantinos Tryfonidis2 and D
Reports & Statements
Interview with Dr. Dimitrios Zardavas, Associate Scientific Director
www.bigagainstbreastcancer.org
Congratulations for presenting the results of this analysis at the recent ASCO annual meeting, and could you please describe the award you received for this ...
News | BIG against breast cancer
www.bigagainstbreastcancer.org
Interview with Dr. Dimitrios Zardavas, Associate Scientific Director at BIG Regarding his analysis of PIK3CA mutations’ prognostic relevance in early ...
Emerging targeted agents in metastatic breast cancer | Nature Reviews...
www.nature.com
There have been great advances in the treatment of patients with breast cancer, with novel targeted agents having a great impact on treatment at all stages of...
Clinical management of breast cancer heterogeneity | Nature Reviews...
www.nature.com
Traditionally, intertumour heterogeneity in breast cancer has been documented in terms of different histological subtypes, treatment sensitivity profiles, and...
Miscellaneous
Dimitrios Zardavas, MD | LinkedIn
www.linkedin.com
View Dimitrios Zardavas, MD's professional profile on LinkedIn. LinkedIn is the world's largest business network, helping professionals like Dimitrios Zardavas, MD
Dimitrios Zardavas, MD | LinkedIn
www.linkedin.com
Dimitrios Zardavas, MD. Associate Scientific Director, Breast International Group (BIG) Location Brussels, Brussels Capital Region, Belgium Industry
Dimitrios Zardavas - Google Scholar Citationsscholar.google.com/citations?user=E8ziCS4AAAAJ&hl=en
scholar.google.com
67, Efficacy of adjuvant trastuzumab for patients with human epidermal growth factor receptor 2–positive early breast cancer and tumors≤ 2 cm: a ...
Auch hier waren Partner mit an Bord: Dimitrios Zardavas,...
www.abcsg.org
Auch hier waren Partner mit an Bord: Dimitrios Zardavas, Stellvertretender Wissenschaftlicher Direktor der Breast International Group.
Efficacy of Adjuvant Trastuzumab for Patients With...
hwmaint.jco.ascopubs.org
Conception and design: Ciara C. O'Sullivan, Edith A. Perez, Heikki Joensuu, Joseph P. Costantino, Priya Rastogi, Dimitrios Zardavas, Jo Anne Zujewski, Richard D. Gelber.
Luminal B Breast Cancer: Molecular Characterization, Clinical...
hwmaint.jco.ascopubs.org
Luminal B Breast Cancer: Molecular Characterization, Clinical Management, and Future Perspectives Felipe Ades, Dimitrios Zardavas, Ivana Bozovic-Spasojevic, Lina
43: Cancer of the breast, Martine Piccart, Toral Gathani, Dimitrios...
www.ndph.ox.ac.uk
Publications; 43: Cancer of the breast, Martine Piccart, Toral Gathani, Dimitrios Zardavas, Hatem A. Azim Jr., Christos Sotiriou, Giuseppe Viale, Emiel J T Rutgers ...
(PDF) Luminal B breast cancer: molecular characterization, clinical...
www.academia.edu
Gene expression profiling has reshaped our understanding of breast cancer by defining and characterizing four main intrinsic molecular subtypes: human...
Cardiotoxicity of systemic agents used in breast cancer —...
moh-it.pure.elsevier.com
Cardiotoxicity of systemic agents used in breast cancer. Felipe Ades, Dimitrios Zardavas, Ana Catarina Pinto, Carmen Criscitiello, Philippe Aftimos, Evandro De ...
CrossRef Text and Data Mining - Cancer Research and Treatment
www.e-crt.org
Emerging targeted agents for HER2-positive breast cancer. Dimitrios Zardavas, Martine Piccart. Handbook of HER2-Targeted Agents in Breast ...
Endocrine treatment in breast cancer: Cure, resistance and beyond...
experts.illinois.edu
Endocrine treatment in breast cancer: Cure, resistance and beyond. Konstantinos Tryfonidis, Dimitrios Zardavas, Benita S. Katzenellenbogen, ...
PYTHIA: A phase II study of palbociclib plus fulvestrant for...
oncologypro.esmo.org
Presenter, Dimitrios Zardavas. Citation, Annals of Oncology (2017) 28 (suppl_5): v74-v annonc/mdx365. Authors, D. Zardavas1, ...
Progress in adjuvant systemic therapy for breast cancer |...
oncology.medicinematters.com
... systemic therapy for breast cancer. Journal: Nature Reviews Clinical Oncology. Authors: Noam F. Pondé, Dimitrios Zardavas, Martine Piccart.
Tumor PIK3CA Genotype and Prognosis in Early-Stage Breast Cancer: A...
researchportal.helsinki.fi
Dimitrios Zardavas, Luc te Marvelde, Roger L. Milne, Debora Fumagalli, George Fountzilas, Vassiliki Kotoula, Evangelia Razis, George ...
Tumor PIK3CA genotype and prognosis in early-stage breast cancer: A...
research.birmingham.ac.uk
author = "Dimitrios Zardavas and {Te Marvelde}, Luc and Milne, {Roger L.} and Debora Fumagalli and George Fountzilas and Vassiliki Kotoula and Evangelia ...
Related search requests for Dimitrios Zardavas
| Vassiliki Kotoula Debora Fumagalli |
People Forename "Dimitrios" (1248) Name "Zardavas" (2) |
sorted by relevance / date